Know Cancer

or
forgot password
  • cancer clinical trials in wichita, KS

  • Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Cancer Center of Kansas - Main Office
    Wichita, Kansas 67214
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
    Via Christi Regional Medical Center

    Trial Locations
    Via Christi Regional Medical Center
    Associates in Womens Health
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Cancer Center of Kansas - Main Office
    Gastrointestinal Stromal Tumor
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Wichita CCOP

    Trial Locations
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Cancer Center of Kansas - Main Office
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Associates in Womens Health

    Trial Locations
    Associates in Womens Health
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Cancer Center of Kansas - Main Office
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Via Christi Cancer Center at Via Christi Regional Medical Center

    Trial Locations
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Leukemia
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Associates in Womens Health

    Trial Locations
    Associates in Womens Health
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Cancer Center of Kansas - Main Office
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Via Christi Cancer Center at Via Christi Regional Medical Center

    Trial Locations
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Lung Cancer
    Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Breast Cancer, Lymphedema, Perioperative/Postoperative Complications
    S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Lymphoma
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Wichita CCOP

    Trial Locations
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Cancer Center of Kansas - Main Office
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Esophageal Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Via Christi Cancer Center at Via Christi Regional Medical Center

    Trial Locations
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Breast Cancer
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Wichita CCOP

    Trial Locations
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer